Expression of membrane cofactor protein (MCP, CD46) in human liver diseases

British Journal of Cancer

Volumn 80, Issue 11, 1999, Pages 1820-1825

  Kinugasa, N ^a   Higashi, T ^a   Nouso, K ^a   Nakatsukasa, H ^a   Kobayashi, Y ^a   Ishizaki, M ^a   Toshikuni, N ^a   Yoshida, K ^a   Uematsu, S ^a   Tsuji, T ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Complement; Hepatocellular carcinoma; Liver; Membrane cofactor protein

Indexed keywords

MEMBRANE COFACTOR PROTEIN;

ADULT; AGED; ARTICLE; BASOLATERAL MEMBRANE; BILE DUCT; CANCER GRADING; CHRONIC HEPATITIS; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOLOGY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TUMOR VOLUME;

ANTIGENS, CD; ANTIGENS, CD46; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; COMPLEMENT INACTIVATOR PROTEINS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; PROTEIN ISOFORMS;

EID: 0032805048     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690604     Document Type: Article

References (28)

1. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72: 248
2. Bjorge L, Hakulinen J, Wahlström T, Matre R and Meri S (1997) Complement-regulatory proteins in ovarian malignancies. Int J Cancer 70: 14-25
3. Cheung N-KV, Walter EI, Smith-Mensah WH, Tatnoff WD, Tykocinski ML and Medof ME (1988) Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro. J Clin Invest 81: 1122-1128
4. Davies A, Simmons DL, Hale G, Harrison RA, Tighe H, Lachmann PJ and Waldmann H (1989) CD59, an LY-6 like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 170: 637-645
5. Gofter A, Blok VT, Haasnoot WHB, Ensink NG, Daha MR and Fleuren GJ (1996) Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis. Lab Invest 74: 1039-1049
6. Hakulinen J and Meri S (1994) Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells. Lab Invest 71: 820-827
7. Hofman P, Hsi B-L, Manie S, Fenichel P, Thyss A and Rossi B (1994) High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas; a preventive mechanism of malignant tumor cells against complement attack? Breast Cancer Res Treat 32: 213-219
8. Hourcade D, Kolers VM and Atkinson JP (1989) The regulators of complement activation (RCA) gene cluster. Adv Immunol 45: 381-416
9. Inoue H, Mizuno M, Uesu T, Ueki T and Tsuji T (1994) Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer. Acta Med Okayama 48: 271-277
10. Johnstone RW, Loveland BE and Mekenzie IFC (1993) Identification and quantification of complement regulator CD46 on normal human tissues. Immunology 79: 341-347
11. Lachmann PJ (1991) The control of homologous lysis. Immunol Today 12: 312-315
12. Liszewski MK, Post TW and Atkinson JP (1991) Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Anna Rev Immunol 9: 431-460
13. Liver Cancer Study Group of Japan (1989) The general rules for the clinical and pathological study of primary liver cancer. Jpn J Surg 19: 98-129
14. Lublin DM and Atkinson JP (1989) Decay-accelerating factor; biochemistry, molecular biology and function. Annu Rev Immunol 7: 35-58
15. Mäenpää A, Junnikkala S, Hakulinen J, Timonen T and Meri S (1996) Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas. Am J Pathol 148: 1139-1152
16. Maisner A, Liszewski MK, Atkinson JP, Schwartz-Albiez R and Herrler G (1996) Two different cytoplasmic tails direct isoforms of the membrane cofactor protein (CD46) to the basolateral surface of Madin-Darby canine kidney cells. J Biol Chem 271: 18853-18858
17. Matsumoto M, Seya T and Nagasawa S (1992) Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement. Biochem J 281: 493-499
18. Matsumura N, Tagami H, Hotta T, Takemura S, Yoshikawa T and Kondo M (1981) Serum complement profile and its clinical significance in patients with hepatocellular carcinoma and liver cirrhosis. Nippon Shokakibyo Gakkai Zassi 78: 1753-1759
19. McNearney T, Ballard L, Seya T and Atkinson JP (1989) Membrane cofactor protein of complement is present on human fibroblast, epithelial and endothelial cells. J Clin Invest 84: 538-545
20. Nagura H, Hasegawa H, Yoshimura S and Watanabe K (1985) The third (C3) and fourth (C4) components of complement in human liver. Immunocytochemical evidence for hepatocytes as the site of synthesis. Acta Pathol Jpn 35: 71-78
21. Nichans GA, Cherwitz DL, Staley NA, Knapp DJ and Dalmasso AP (1996) Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay accelerating factor), and CD59 (protectin). Am J Pathol 149: 129-142
22. Scoazee J-Y, Delautier D, Moreau A, Durand F, Degott C, Benhamou J-P, Belghiti J and Feldmann G (1994) Expression of complement-regulatory proteins in normal and UW-preserved human liver. Gastroenterology 107: 505-516
23. Seya T and Atkinson JP (1989) Functional properties of membrane cofactor protein of complement. Biochem J 264: 581-588
24. Seya T, Hara T, Matsumoto M, Sugita Y and Akedo H (1990) Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46). J Exp Med 172: 1673-1680
25. Seya T, Matsumoto M, Hara T, Hatanaka M, Masaoka T and Akedo H (1994) Distribution of C3-step regulatory proteins of the complement system, CD35 (CR1), CD46 (MCP), and CD55 (DAF), in hematological malignancies. Leuk Lymphoma 12: 395-400
26. Simpson KL, Houlihan JM and Holmes CH (1993) Complement regulatory proteins in early human fetal life: CD59, membrane cofactor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver. Immunology 80: 183-190
27. Simpson KL, Jones A, Norman S and Holmes CH (1997) Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease. Am J Pathol 151: 1455-1467
28. Theodore W, Post M, Liszewsky K, Anams EM, Tedja I, Miller A and Atkinson JP (1991) Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype. J Exp Med 174: 93-102